{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:11:27Z","timestamp":1793927487384,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.atherosclerosis.2022.06.1011","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:03:46Z","timestamp":1655809426000},"page":"15-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions"],"prefix":"10.1016","volume":"355","author":[{"given":"Beate","family":"Jahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Dieplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Ebenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Conrads-Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Rochau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Stojkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-7671","authenticated-orcid":false,"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOL.0000000000000300","article-title":"A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries","volume":"27","author":"Mundal","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib2","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.CR003","article-title":"Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017","volume":"25","author":"Harada-Shiba","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehv602","article-title":"Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death","volume":"37","author":"Krogh","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib5","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib6","first-page":"464","article-title":"The cost-effectiveness of genetic screening for familial hypercholesterolemia: a systematic review","volume":"29","author":"Rosso","year":"2017","journal-title":"Ann. Ig. Med. Preventiva Comunita"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ijcard.2013.01.280","article-title":"A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia","volume":"167","author":"Ademi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0266462313000160","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) statement","volume":"29","author":"Husereau","year":"2013","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib11","unstructured":"OECD. Purschasing Power Parities (PPP). OECD."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib12","unstructured":"OECD. Inflation (CPI) OECD."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/cer.15.38","article-title":"Systematic overview of cost-effectiveness thresholds in ten countries across four continents","volume":"4","author":"Schwarzer","year":"2015","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jpm7030010","article-title":"Value-based pricing and reimbursement in personalised healthcare: introduction to the basic health economics","volume":"7","author":"Garrison","year":"2017","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.05.007","article-title":"Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?","volume":"304","author":"Ademi","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.05.021","article-title":"Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales","volume":"275","author":"Crosland","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2018.05.047","article-title":"Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: a cost-utility analysis","volume":"275","author":"McKay","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/pubmed\/fdg010","article-title":"Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening","volume":"25","author":"Marks","year":"2003","journal-title":"J. Publ. Health Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2010.213975","article-title":"Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies","volume":"97","author":"Nherera","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"Lazaro","year":"2017","journal-title":"J. Cllinic. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0300-8932(09)70021-1","article-title":"[Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia]","volume":"62","author":"Oliva","year":"2009","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib25","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1053\/euhj.2002.3281","article-title":"Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands","volume":"23","author":"Marang-van de Mheen","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2004-822992","article-title":"Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands","volume":"4","author":"Wonderling","year":"2004","journal-title":"Semin. Vasc. Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2018.01.036","article-title":"The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland","volume":"270","author":"Pelczarska","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijcard.2014.12.070","article-title":"Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States","volume":"181","author":"Chen","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J. Cllinic. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/heapol\/czw096","article-title":"Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds","volume":"32","author":"Robinson","year":"2017","journal-title":"Health Pol. Plann."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.zefq.2013.10.020","article-title":"When is enough evidence enough? - using systematic decision analysis and value-of-information analysis to determine the need for further evidence","volume":"107","author":"Siebert","year":"2013","journal-title":"Z Evid. Fortbild Qual. Gesundhwes."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s41669-020-00227-6","article-title":"Value of information analysis: are we There yet?","volume":"5","author":"Tuffaha","year":"2021","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X12454577","article-title":"SMDM modeling good research practices Task Force I. Modeling good research practices--overview: a report of the ISPOR-SMDM modeling good research practices Task force-1","volume":"32","author":"Caro","year":"2012","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10198-003-0205-2","article-title":"When should decision-analytic modeling be used in the economic evaluation of health care?","volume":"4","author":"Siebert","year":"2003","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0272989X12455463","article-title":"State-transition modeling: a report of the ISPOR-SMDM modeling good research practices Task force-3","volume":"32","author":"Siebert","year":"2012","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0272989X12454941","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices Task force-2","volume":"32","author":"Roberts","year":"2012","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","article-title":"Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices Task force--7","volume":"15","author":"Eddy","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib39","series-title":"Cost-effectiveness in Health and Medicine","author":"Neumann","year":"2016"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.a.34368","article-title":"The evaluation of cascade testing for familial hypercholesterolemia","volume":"158a","author":"Morris","year":"2012","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib41","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: the Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2017.03.019","article-title":"A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist","volume":"41","author":"Girelli","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/2047487318766954","article-title":"Health literacy in familial hypercholesterolemia: a cross-national study","volume":"25","author":"Hagger","year":"2018","journal-title":"Eur J. Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/jpm8040035","article-title":"Patient and provider perspectives on a decision aid for familial hypercholesterolemia","volume":"8","author":"Farwati","year":"2018","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib46","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.atherosclerosis.2022.06.1011_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11886-016-0723-z","article-title":"Familial hypercholesterolaemia in the era of genetic testing","volume":"18","author":"Hughes","year":"2016","journal-title":"Curr. Cardiol. Rep."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022012989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022012989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:49:19Z","timestamp":1758156559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022012989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"alternative-id":["S0021915022012989"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.06.1011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.06.1011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}